Clinical Trial Update: Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating melatonin as a neuroprotective therapy in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: University of Florida | Conditions: Hypoxic Ischemic Encephalopathy | EARLY_Phase 1 | Status: RECRUITING